Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Acute Coronary Syndrome V: Nursing Management

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma proteomics in septic shock and alcohol-related pancreatitis: a hyaluronan-centered approach.

Clinical proteomics·2025

Same author

Author Response: "A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door-In-Door-Out Times in Thrombectomy Patients: A Retrospective Analysis".

European journal of neurology·2025

Same author

A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door-In-Door-Out Times in Thrombectomy Patients: A Retrospective Analysis.

European journal of neurology·2025

Same author

Development and internal validation of an algorithm for estimating mortality in patients encountered by physician-staffed helicopter emergency medical services.

Scandinavian journal of trauma, resuscitation and emergency medicine·2024

Same author

Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis sepsis.

Intensive care medicine experimental·2023

Same author

HIGH-MOLECULAR-WEIGHT HYALURONAN-A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS?

Shock (Augusta, Ga.)·2023

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Statins for post resuscitation syndrome.

Antti Kämäräinen¹, Ilkka Virkkunen, Tom Silfvast

¹Medical School, University of Tampere, Tampere, Finland. antti.kamarainen@uta.fi

Medical Hypotheses

|March 4, 2009

Summary

This summary is machine-generated.

Statins may benefit cardiac arrest survivors by reducing inflammation and improving vascular function. Further clinical trials are needed to confirm the efficacy of statin therapy in post resuscitation syndrome.

Related Experiment Videos

Last Updated: Jun 25, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Area of Science:

Cardiology
Pharmacology
Critical Care Medicine

Background:

Sudden cardiac arrest (SCA) survivors develop post-resuscitation syndrome (PRS), a complex disorder involving ischemia/reperfusion injury.
PRS is characterized by systemic inflammation, altered coagulation, impaired vascular reactivity, and oxidative stress, leading to multi-organ dysfunction, particularly in the brain.
Statins, known for lipid-lowering, possess pleiotropic effects including anti-inflammatory, antioxidant, and immunomodulatory properties, beneficial in cardiovascular diseases.

Purpose of the Study:

To investigate the potential benefits of early statin administration in patients following successful resuscitation from SCA.
To explore how statins' pleiotropic effects might mitigate PRS by modulating inflammatory and coagulation responses, reducing oxidative stress, and enhancing vascular reactivity.

Main Methods:

The study proposes a hypothesis for statin use in PRS.
It suggests a randomized, controlled trial (RCT) with standardized post-resuscitation care is necessary for clinical validation.
Consideration of a parenteral statin formulation for adequate dosing is mentioned.

Main Results:

The abstract presents a hypothesis, not experimental results.
It highlights that statins have shown beneficial effects in experimental settings and non-cardiac arrest patients.
The generally good tolerance and minimal adverse effects of statin therapy are noted.

Conclusions:

Early statin administration is hypothesized to be beneficial in resuscitated patients by mitigating PRS.
Statins may offer therapeutic advantages through their anti-inflammatory, antioxidant, and vascular effects.
Further robust clinical trials are required to confirm the efficacy and optimal delivery of statins in the post-resuscitation phase.